Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

22.24

+0.24 (1.09%)

At close: Mar 9, 2026, 4:00 PM EDT

23.00

+0.76 (3.42%)

After-hours: Mar 9, 2026, 4:24 PM EDT

Pacira BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	21.44	-99.56	41.96	15.91	41.98	145.52
Depreciation & Amortization	90.92	78.79	75.57	91.5	28.55	19.91
Stock-Based Compensation	56.27	51.17	47.9	48.09	42.25	39.92
Other Adjustments	13.64	177.51	35	6.21	38.45	-94.52
Change in Receivables	-14.59	-7.75	-7.16	-2.08	-10.43	-5.52
Changes in Inventories	-45.8	-20.93	-8.29	2.49	-4.47	-6.35
Changes in Accounts Payable	-2.99	3.08	0.92	6.27	-10.26	-3.31
Changes in Accrued Expenses	-7.97	11.72	-22.04	-19.86	5.45	-6
Changes in Other Operating Activities	-5.95	-4.65	-9.21	-3.26	-5.8	-12.62
Operating Cash Flow	141.44	189.39	154.65	145.27	125.72	77.03
Operating Cash Flow Growth	-30.61%	22.46%	6.45%	15.56%	63.20%	9.23%
Capital Expenditures	-17.23	-10.64	-15.16	-30.08	-45.87	-37.8
Purchases of Investments	-159.27	-252.21	-144.37	-400.69	-628.68	-547.68
Proceeds from Sale of Investments	273.61	179.57	237.07	237.58	1,078	307.87
Payments for Business Acquisitions	-25.05	-	-	-	-420.04	-
Other Investing Activities	-	-	-	-32	-4	-
Investing Cash Flow	79.78	-83.28	77.54	-225.19	-20.79	-277.61
Long-Term Debt Issued	-	287.5	149.55	-	363.75	314.71
Long-Term Debt Repaid	-310.61	-222.14	-363.75	-427.69	-	-176.79
Net Long-Term Debt Issued (Repaid)	-310.61	65.37	-214.2	-427.69	363.75	137.92
Issuance of Common Stock	2.5	2.3	4.75	27.34	26.66	135.56
Repurchase of Common Stock	-80.61	-25.49	-0.11	-	-	-
Net Common Stock Issued (Repurchased)	-78.89	-23.19	4.64	27.34	26.66	135.56
Other Financing Activities	-2.2	-36.06	-6.91	-1.18	-9.71	-51.17
Financing Cash Flow	-319.93	17.36	-183.03	-401.53	380.69	222.3
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.24	-	-	-	-	-
Net Cash Flow	-114.32	123.48	49.16	-481.44	485.62	21.73
Free Cash Flow	124.2	178.75	139.49	115.2	79.85	39.23
Free Cash Flow Growth	-30.52%	28.15%	21.09%	44.27%	103.54%	-35.01%
FCF Margin	17.33%	25.50%	20.67%	17.28%	14.75%	9.13%
Free Cash Flow Per Share	2.68	3.87	2.68	2.48	1.75	0.90
Levered Free Cash Flow	-278.19	23.18	-150.45	-364.71	373.34	237.27
Unlevered Free Cash Flow	32.28	-58.38	81.41	118.86	34.54	289.58

Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q